Over recent years there has been much interest in how the Amyloid-β Precursor Protein (APP) may contribute to autism spectrum disorder (ASD) and Fragile X Syndrome (FXS), particularly to the macrocephaly often seen in these disorders (Sokol and Lahiri, 2023). The gene discussed is APP; the disease is fragile X syndrome.